Huntsman (NYSE:HUN – Free Report) had its price objective lowered by Mizuho from $23.00 to $21.00 in a report published on Tuesday,Benzinga reports. The firm currently has a neutral rating on the basic materials company’s stock.
A number of other research analysts have also weighed in on HUN. UBS Group cut their price target on shares of Huntsman from $24.00 to $23.00 and set a “neutral” rating on the stock in a research note on Tuesday, November 5th. Wells Fargo & Company dropped their price target on Huntsman from $26.00 to $25.00 and set an “overweight” rating on the stock in a research note on Wednesday, November 6th. Citigroup reduced their price objective on Huntsman from $22.00 to $19.00 and set a “neutral” rating for the company in a research report on Wednesday, December 18th. Finally, Royal Bank of Canada dropped their target price on Huntsman from $23.00 to $20.00 and set a “sector perform” rating on the stock in a research report on Thursday, December 19th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and three have given a buy rating to the company. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $23.75.
Check Out Our Latest Research Report on Huntsman
Huntsman Stock Down 2.7 %
Huntsman (NYSE:HUN – Get Free Report) last released its quarterly earnings data on Monday, November 4th. The basic materials company reported $0.10 EPS for the quarter, meeting analysts’ consensus estimates of $0.10. The business had revenue of $1.54 billion during the quarter, compared to analysts’ expectations of $1.55 billion. Huntsman had a negative net margin of 1.99% and a negative return on equity of 0.03%. The firm’s quarterly revenue was up 2.3% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.15 EPS. On average, analysts predict that Huntsman will post 0.09 earnings per share for the current year.
Huntsman Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Tuesday, December 31st. Stockholders of record on Friday, December 13th were paid a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a dividend yield of 6.06%. The ex-dividend date was Friday, December 13th. Huntsman’s dividend payout ratio is presently -144.93%.
Insider Buying and Selling at Huntsman
In other news, Director Mary C. Beckerle sold 20,201 shares of Huntsman stock in a transaction on Wednesday, November 6th. The stock was sold at an average price of $21.42, for a total transaction of $432,705.42. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 5.60% of the company’s stock.
Institutional Trading of Huntsman
Several hedge funds and other institutional investors have recently bought and sold shares of HUN. Matrix Trust Co acquired a new position in shares of Huntsman during the 3rd quarter worth approximately $25,000. True Wealth Design LLC acquired a new stake in shares of Huntsman in the third quarter valued at approximately $62,000. Capital Performance Advisors LLP acquired a new stake in Huntsman during the third quarter worth approximately $78,000. Quarry LP grew its position in Huntsman by 64.8% during the second quarter. Quarry LP now owns 3,664 shares of the basic materials company’s stock worth $83,000 after buying an additional 1,441 shares in the last quarter. Finally, Rossmore Private Capital bought a new position in Huntsman during the 3rd quarter worth $202,000. Institutional investors and hedge funds own 84.81% of the company’s stock.
About Huntsman
Huntsman Corporation manufactures and sells diversified organic chemical products worldwide. The company operates in three segments: Polyurethanes, Performance Products, and Advanced Materials. The Polyurethanes segment offers polyurethane chemicals, including methyl diphenyl diisocyanate, polyether and polyester polyols, and thermoplastic polyurethane; and aniline, benzene, nitrobenzene and other co-products.
Featured Stories
- Five stocks we like better than Huntsman
- How to Calculate Options Profits
- MercadoLibre: Latin America’s Digital Titan Just Got Cheaper
- Best Stocks Under $10.00
- Breaking Down Pegasystems, A Wedbush Top AI Pick for 2025
- How to Invest in Blue Chip Stocks
- Shutterstock and Getty: A $3.7 Billion Visual Content Giant
Receive News & Ratings for Huntsman Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Huntsman and related companies with MarketBeat.com's FREE daily email newsletter.